(PDF) In Vitro Activity of Saperconazole (R66 905) Compared

In Vitro Activity of Saperconazole (R66 905) Compared With Amphotericin B and Itraconazole againstAspergillus Species

European Journal of Clinical Microbiology and Infectious Diseases - Germany

doi 10.1007/bf01967104

Full Text

Open PDF

Abstract

Available in full text

Date

January 1, 1991

Authors

D. W. Denning

Publisher

Springer Science and Business Media LLC

Related search

In Vitro Activities of Terbinafine Against Aspergillus Species in Comparison With Those of Itraconazole and Amphotericin B

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2001

English

Saperconazole Therapy of Murine Disseminated Candidiasis: Efficacy and Interactions With Amphotericin B.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1994

English

In Vitro Activity of BMS-181184 Compared With Those of Fluconazole and Amphotericin B Against Various Candida Spp.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1996

English

Effect of pH on the in Vitro Activities of Amphotericin B, Itraconazole, and Flucytosine Against Aspergillus Isolates

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2004

English

In Vitro Activity of Amphotericin B Cochleates Against Leishmania Chagasi

Memorias do Instituto Oswaldo Cruz

Medicine

Microbiology

2011

English

Comparison of Antifungal Activity of Amphotericin B Deoxycholate Suspension With That of Amphotericin B Cholesteryl Sulfate Colloidal Dispersion.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1992

English

In Vitro and in Vivo Activity of Amphotericin B-Lipid Formulations Against Experimental Trypanosoma Cruzi Infections.

American Journal of Tropical Medicine and Hygiene

English

Enhancement of the in Vitro Activity of Amphotericin B Against Aspergillus Spp. By Tetracycline Analogs.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1984

English

In Vitro Activity of Fluvastatin, a Cholesterol-Lowering Agent, and Synergy With Flucanazole and Itraconazole Against Candida Species and Cryptococcus Neoformans.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1997

English

Amanote Research

In Vitro Activity of Saperconazole (R66 905) Compared With Amphotericin B and Itraconazole againstAspergillus Species

European Journal of Clinical Microbiology and Infectious Diseases - Germany

doi 10.1007/bf01967104

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

In Vitro Activities of Terbinafine Against Aspergillus Species in Comparison With Those of Itraconazole and Amphotericin B

Saperconazole Therapy of Murine Disseminated Candidiasis: Efficacy and Interactions With Amphotericin B.

In Vitro Activity of BMS-181184 Compared With Those of Fluconazole and Amphotericin B Against Various Candida Spp.

Effect of pH on the in Vitro Activities of Amphotericin B, Itraconazole, and Flucytosine Against Aspergillus Isolates

In Vitro Activity of Amphotericin B Cochleates Against Leishmania Chagasi

Comparison of Antifungal Activity of Amphotericin B Deoxycholate Suspension With That of Amphotericin B Cholesteryl Sulfate Colloidal Dispersion.

In Vitro and in Vivo Activity of Amphotericin B-Lipid Formulations Against Experimental Trypanosoma Cruzi Infections.

Enhancement of the in Vitro Activity of Amphotericin B Against Aspergillus Spp. By Tetracycline Analogs.

In Vitro Activity of Fluvastatin, a Cholesterol-Lowering Agent, and Synergy With Flucanazole and Itraconazole Against Candida Species and Cryptococcus Neoformans.